Trimel Pharmaceuticals Corp. (OTCMKTS:TRLPF) Scheduled to Post Earnings on Friday
Trimel Pharmaceuticals Corp. (OTCMKTS:TRLPF) is scheduled to announce its earnings results before the market opens on Friday, August 11th. Analysts expect the company to announce earnings of ($0.01) per share for the quarter.
Trimel Pharmaceuticals Corp. (OTCMKTS TRLPF) opened at 0.0845 on Wednesday. Trimel Pharmaceuticals Corp. has a 12-month low of $0.07 and a 12-month high of $0.20. The stock has a market cap of $18.01 million, a P/E ratio of 8.4500 and a beta of 1.38. The firm’s 50 day moving average price is $0.09 and its 200-day moving average price is $0.09.
TRADEMARK VIOLATION NOTICE: “Trimel Pharmaceuticals Corp. (OTCMKTS:TRLPF) Scheduled to Post Earnings on Friday” was posted by Daily Political and is owned by of Daily Political. If you are viewing this story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The correct version of this story can be read at https://www.dailypolitical.com/2017/08/09/trimel-pharmaceuticals-corp-otcmktstrlpf-scheduled-to-post-earnings-on-friday.html.
About Trimel Pharmaceuticals Corp.
Trimel Pharmaceuticals Corporation is a specialty pharmaceutical company involved in the sale, distribution, and development of products with a focus in men’s health, women’s health and respiratory medicine. The Corporation holds a license for the development and marketing rights to certain products utilizing a nasal gel drug delivery technology platform and owns a novel unit-dose dry power inhaler / nasal dispersion system.
Receive News & Ratings for Trimel Pharmaceuticals Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trimel Pharmaceuticals Corp. and related companies with MarketBeat.com's FREE daily email newsletter.